BCMA-targeted CAR-T therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BCMA-targeted CAR-T therapy, covering 2019-06-25 to 2023-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]